Financial results - SILVAPHARM S.R.L.

Financial Summary - Silvapharm S.r.l.
Unique identification code: 19089271
Registration number: J33/1253/2006
Nace: 4773
Sales - Ron
122.079
Net Profit - Ron
5.565
Employees
1
Open Account
Company Silvapharm S.r.l. with Fiscal Code 19089271 recorded a turnover of 2025 of 122.079, with a net profit of 5.565 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Silvapharm S.r.l.

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Sales - EUR 95.859 104.929 114.100 120.406 149.796 132.712 150.968 159.207 164.035 122.079
Total Income - EUR 95.864 104.935 114.105 120.412 149.805 132.724 150.981 159.274 164.050 122.825
Total Expenses - EUR 92.427 99.689 104.574 108.953 130.701 117.739 133.654 143.757 153.233 116.226
Gross Profit/Loss - EUR 3.437 5.246 9.531 11.459 19.104 14.985 17.327 15.517 10.817 6.599
Net Profit/Loss - EUR 2.478 4.197 8.390 10.255 17.680 13.658 15.817 13.965 9.121 5.565
Employees 2 2 2 2 2 2 2 2 2 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -24.6%, from 164.035 euro in the year 2024, to 122.079 euro in 2025. The Net Profit decreased by -3.435 euro, from 9.121 euro in 2024, to 5.565 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Silvapharm S.r.l.

Rating financiar

Financial Rating -
SILVAPHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Silvapharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Silvapharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Silvapharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Silvapharm S.r.l. - CUI 19089271

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Fixed Assets 6.776 3.613 722 0 0 0 0 0 0 0
Current Assets 36.274 34.851 46.111 46.223 52.613 58.663 50.123 55.997 49.880 6.385
Inventories 18.724 17.608 15.571 15.284 17.931 16.341 18.049 19.622 21.699 0
Receivables 2.416 10.799 14.748 12.628 17.969 14.880 17.286 15.308 10.657 2.820
Cash 15.133 6.444 15.792 18.311 16.713 27.443 14.788 21.068 17.525 3.565
Shareholders Funds 2.523 4.240 8.433 10.297 17.721 20.474 24.188 23.928 17.637 5.604
Social Capital 45 44 43 42 41 40 41 40 40 40
Debts 40.527 34.224 38.399 35.926 34.891 38.189 25.935 32.069 32.243 781
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 5.0415 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 6.385 euro in 2025 which includes Inventories of 0 euro, Receivables of 2.820 euro and cash availability of 3.565 euro.
The company's Equity was valued at 5.604 euro, while total Liabilities amounted to 781 euro. Equity decreased by -11.797 euro, from 17.637 euro in 2024, to 5.604 in 2025.

Risk Reports Prices

Reviews - Silvapharm S.r.l.

Comments - Silvapharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.